Cargando…
ACAM2000™: The new smallpox vaccine for United States Strategic National Stockpile
Smallpox was eradicated more than 30 years ago, but heightened concerns over bioterrorism have brought smallpox and smallpox vaccination back to the forefront. The previously licensed smallpox vaccine in the United States, Dryvax(®) (Wyeth Laboratories, Inc.), was highly effective, but the supply wa...
Autores principales: | Nalca, Aysegul, Zumbrun, Elizabeth E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2880337/ https://www.ncbi.nlm.nih.gov/pubmed/20531961 |
Ejemplares similares
-
Adventitious Agents and Smallpox Vaccine in Strategic National
Stockpile
por: Murphy, Frederick A., et al.
Publicado: (2005) -
Monkeypox in Patient Immunized with ACAM2000 Smallpox Vaccine During 2022 Outbreak
por: Turner, Matthew, et al.
Publicado: (2022) -
SG-APSIC1035: Prospective safety surveillance study of ACAM2000 smallpox vaccine in deployed military personnel
por: Yeo, Kevin, et al.
Publicado: (2023) -
ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain) – a second-generation smallpox vaccine for biological defense
por: Monath, Thomas P., et al.
Publicado: (2004) -
Should Remaining Stockpiles of Smallpox Virus (Variola) Be Destroyed?
por: Weinstein, Raymond S.
Publicado: (2011)